CytoMed Therapeutics Limited Equity
CytoMed Therapeutics Limited (GDTC) had Equity of SGD 6.85 million as of 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Notes
ifrs-full:Equity · last filed 2026-03-31
- 2025-12-31: Equity 6.85M SGD.
- 2024-12-31: Equity 9.04M SGD.
- 2023-12-31: Equity 11.24M SGD.
- 2022-12-31: Equity 586.30K SGD.
SGD
| Period end | Equity |
|---|---|
| 2025-12-31 | 6.85M SGD 20-F · filed 2026-03-31 |
| 2024-12-31 | 9.04M SGD 20-F · filed 2026-03-31 |
| 2023-12-31 | 11.24M SGD 20-F · filed 2026-03-31 |
| 2022-12-31 | 586.30K SGD 20-F · filed 2026-03-31 |
| 2021-12-31 | 2.59M SGD 20-F · filed 2025-04-28 |
| 2020-12-31 | 475.78K SGD 20-F · filed 2024-04-22 |
| 2019-12-31 | 1.92M SGD 20-F · filed 2023-05-01 |
USD
| Period end | Equity |
|---|---|
| 2025-12-31 | $5.33M 20-F · filed 2026-03-31 |
| 2024-12-31 | $6.62M 20-F · filed 2025-04-28 |
| 2023-12-31 | $8.52M 20-F · filed 2024-04-22 |
| 2022-12-31 | $437.40K 20-F · filed 2023-05-01 |